The study of ideal anesthetic regimen for drug-induced sleep endoscopy based on EEG monitoring in children with obstructive sleep apnea

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023507

Enrollment

Unknown

Registered

2019-05-31

Start date

2018-08-01

Completion date

Unknown

Last updated

2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Interventions

Experimental groups:Different anesthetic drugs

Intravenous ketamine was administered as soon as dexmedetomidine induction

Eligibility

Sex/Gender

All

Age

2 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 2-12 years; 2. ASA I or II; 3. Symptoms of OSA were inconsistent with the results of existing examinations (such as nasopharyngeal lateral X-ray, polysomnography, etc.),and children with residual OSA who had a history of adenoidectomy and/or tonsillectomy 4. Signing informed consent.

Exclusion criteria

Exclusion criteria: The children with a recent history of upper respiratory infections and allergies to ketamine and other drugs were excluded.

Design outcomes

Primary

Measure	Time frame
heart rate;Systolic blood pressure;Diastolic blood pressure;Pulse oxygen saturation;movement;	—

Countries

China

Contacts

Public ContactZhang Ruidong

doctorruidong@163.com+86 18221150942

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026